0001190725-16-000403.txt : 20160519 0001190725-16-000403.hdr.sgml : 20160519 20160519181202 ACCESSION NUMBER: 0001190725-16-000403 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160518 FILED AS OF DATE: 20160519 DATE AS OF CHANGE: 20160519 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 161664284 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1245 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-05-18 0 0001576263 Mirati Therapeutics, Inc. MRTX 0001197355 FUCHS HENRY J C/O MIRATI THERAPEUTICS INC. 9393 TOWN CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 1 0 0 0 Option Grant (Right to Buy) 15.72 2016-05-18 4 A 0 10000 0 A 2026-05-17 Common Stock 10000 10000 D The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant. /s/ Jamie A. Donadio, Attorney-in-Fact 2016-05-19